We sought to compare bladder emptying function in normal women during the p
roliferative and secretory phases of the menstrual cycle and to evaluate wh
ether urethral catheterization affected uroflowmetry parameters. Forty-nine
normal volunteers (ages 19-42 years) were recruited and underwent uroflowm
etry in the proliferative and secretory phases of the menstrual cycle. A se
rum progesterone level of <3.0 ng/mL defined the proliferative phase. Durin
g the proliferative phase, volunteers underwent uroflowmetry analysis when
a sensation of fullness was appreciated. A post-void residual volume was de
termined, and the bladder was filled with 400 mt of normal saline. Repeat u
roflowmetry analysis was then performed. This two-step procedure was repeat
ed at a separate visit during the secretory phase. Voided volume, residual
volume, maximum and average flow rates, time-to-maximum flow, and duration
of flow were recorded. Wilcoxon signed-rank tests were used for statistical
analysis. A two-tailed a value of <0.05 defined statistical significance.
Our analysis was limited to the 33 patients whose predicted menstrual datin
g correlated with the obtained progesterone levels. During the follicular p
hase, we found significantly faster maximum (P < 0.0001) and average flow r
ates (P = 0.01), along with a shorter time-to-maximum flow (P < 0.0001) and
shorter duration of flow (P < 0.0001), during the pre-catheterized void th
an the post-catheterized void. Similar results were observed in the secreto
ry phase with the exception of a slightly higher residual volume (P = 0.05)
. No difference was seen in any measured uroflowmetry parameter when compar
ing similar voids between phases of the menstrual cycle. We conclude that w
hen evaluating pre-menopausal patients, uroflowmetry may be scheduled and p
erformed during either phase of the menstrual cycle. (C) 2000 Wiley-Liss, I
nc.